Isoflurane-oxygen anesthesia during coronary artery bypass grafting decreased coronary resistance by 23% but caused myocardial lactate production, indicating global ischemia, in 30% of patients.
Observational (n=10)
Does isoflurane-oxygen anesthesia affect myocardial metabolism and hemodynamics in patients undergoing coronary artery bypass grafting?
Isoflurane anesthesia during CABG can cause coronary vasodilation but may concomitantly lead to anaerobic metabolism and regional ischemia.
Isoflurane-oxygen was given for induction and maintenance of anesthesia to ten patients having coronary artery bypass grafts. All had preserved ventricular function without hypertension or other cardiac lesions; treatment with beta-blocking drugs was maintained until the operation in all patients. Cardiac output, arterial and central pressures, coronary sinus (CS) blood flow, arterial and CS oxygen, Hb, and lactate contents were measured before, six times during, and twice after anesthesia. On induction, systolic arterial pressure was purposely reduced 33% along with systemic resistance by increasing the concentration of isoflurane; cardiac index, heart rate, and coronary flow did not change. Coronary resistance decreased 23% and CS oxygen content increased 56%; but in three of ten patients myocardial lactate production took place, evidence of global ischemia. Induction of anesthesia was not smooth in three patients. Controlled hemodynamic depression could be maintained with isoflurane-oxygen, but the frequency of myocardial lactate production before and after perfusion was greater than with other general anesthetics. Isoflurane dilated portions of the coronary bed but, because anaerobic metabolism occurred concomitantly, the theory that redistribution of flow can take place resulting in ischemic areas of ventricle is supported.
Moffitt et al. (Fri,) conducted a observational in Coronary artery bypass grafts (n=10). Isoflurane-oxygen anesthesia was evaluated on Myocardial lactate production (evidence of global ischemia). Isoflurane-oxygen anesthesia during coronary artery bypass grafting decreased coronary resistance by 23% but caused myocardial lactate production, indicating global ischemia, in 30% of patients.